XML 58 R44.htm IDEA: XBRL DOCUMENT v3.21.2
Acquisitions - Acquired Intangible Assets (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 02, 2021
Jun. 30, 2021
Jun. 30, 2021
Jun. 30, 2020
Acquired Finite-Lived Intangible Assets [Line Items]        
Fair Values   $ 74,000 $ 74,000 $ 131,000
AvKARE and R&S Acquisitions        
Acquired Finite-Lived Intangible Assets [Line Items]        
Fair Values     130,800  
Marketed product rights | Kashiv Specialty Pharmaceuticals, LLC        
Acquired Finite-Lived Intangible Assets [Line Items]        
Fair Values $ 29,500      
Government licenses | AvKARE and R&S Acquisitions        
Acquired Finite-Lived Intangible Assets [Line Items]        
Fair Values     $ 66,700  
Weighted-Average Useful Life     7 years  
Government contracts | AvKARE and R&S Acquisitions        
Acquired Finite-Lived Intangible Assets [Line Items]        
Fair Values     $ 22,000  
Weighted-Average Useful Life     4 years  
National contracts | AvKARE and R&S Acquisitions        
Acquired Finite-Lived Intangible Assets [Line Items]        
Fair Values     $ 28,600  
Weighted-Average Useful Life     5 years  
Customer relationships | AvKARE and R&S Acquisitions        
Acquired Finite-Lived Intangible Assets [Line Items]        
Fair Values     $ 13,000  
Weighted-Average Useful Life     10 years  
Trade name | AvKARE and R&S Acquisitions        
Acquired Finite-Lived Intangible Assets [Line Items]        
Fair Values     $ 500  
Weighted-Average Useful Life     6 years